{"disease":{"id":"otorhinolaryngologic-neoplasms","name":"otorhinolaryngologic neoplasms"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05246891","title":"Rehabilitation Nursing Program in Otolaryngology","phase":"","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"University of Évora","has_results":false},{"nct_id":"NCT06512662","title":"Support Pathway for ENT Cancer Patients in a Support Care Day Hospital","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Clinique Pasteur Lanroze","has_results":false},{"nct_id":"NCT05830240","title":"A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":9,"lead_sponsor_name":"Shanghai Yunying Medical Technology","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}